Managing Director
Medical Cybernetics Incorporated was formed to license and develop technology for the application of computer control to medical and biotechnology procedures. Dr. Lichtenstein’s patents for closed loop medical treatment systems date from 1969. His proprietary technology was originally developed for a NASA project, and subsequently used by the Linkirk Group, Inc. as the basis for an automated artificial kidney system. Dr. Lichtenstein was a Linkirk cofounder, and from 1972 to 1991 Linkirk‘s President. As the principle licensee for the application of Dr. Lichtenstein’s patents and technology to hemodialysis, the Linkirk automated artificial kidney system was developed, and ultimately FDA approved, through sublicensing and consulting agreements with IBM, Control Data Corporation and subsidiaries.
Dr. Lichtenstein is Clinical Assistant Professor, Weil School of Medicine of Cornell University, and was Attending Physician at The New York Hospital, Director of Endocrinology at the affiliated Laguardia Hospital, and the QLI Medical Group. A graduate of Colgate University and the Albert Einstein College of Medicine, Dr. Lichtenstein is a Fellow of both the American College of Endocrinology, and the American College of Physicians. He is a Diplomate of the American Board of Endocrinology and Metabolism, the American Board of Internal Medicine, and the American Board of Medical Examiners. His postgraduate training included an NIH Postdoctoral Endocrinology and Metabolism Research Fellowship at Columbia University College of Physicians and Surgeons, Presbyterian Hospital, a New York University School of Medicine Medical Residency, and a Columbia University College of Physicians and Surgeons Medical Internship. He has been licensed as both a Clinical Laboratory and Nuclear Medicine Laboratory Director,. He is a member of The Endocrine Society, the American Association of Clinical Endocrinologists, the American Diabetes Association, the IEEE , the Association for Computing Machinery, and the American Medical Informatics Association.
A Principle Investigator at the Walter Reed Army Institute of Research, Division of Biochemistry-Automated Analytic Instrumentation, Dr. Lichtenstein assessed clinical laboratory technology, while an Attending Physician at the Walter Reed Army Hospital, and researching brain cell cyclic-AMP response to opiate and anticonvulsant drugs. As an Instructor at the University of California School of Public Health, Berkeley, Dr. Lichtenstein developed an approach to computer simulation for health care planning in the San Francisco Bay Area, an extension of a previous design for evaluation of architectural functions in medical facilities, developed for renovations at Montifiore Hospital’s Institute for Surgical Studies, where he was assisting in laboratory studies of hemorrhagic and endotoxin shock.